Abstract:Objective To study the relationship between Galectin-3 (Gal-3) and atrial fibrillation (AF) in patients with atrial fibrillation and potential mechanisms. Methods A total of 40 AF patients who had normal cardiac function were selected as AF group, and 20 healthy subjects were enrolled as control group. Levels of Gal-3, transforming growth factor-beta 1, Smads protein and precollagen type I carboxy terminal peptide were measured by enzyme-linked immunosorbent assay. Correlation between Gal-3 and other parameters was analyzed. Results Levels of Gal-3, TGF-β1, Smad3 and PICP in AF group were increased significantly compared with those in control group (P < 0.05). Statistical analysis showed that there was a significant positive correlation between Gal-3 and PICP, Gal- 3 and TGF-beta 1, TGF-beta 1 and smad3, and TGF-beta 1 and PICP in AF group (r = 0.695, 0.760, 0.890 and 0.829; all P = 0.001). Conclusions Gal-3 and myocardial fibrosis indices in AF patients increase and Gal-3 may promote myocardial fibrosis by activating TGF- beta 1/Smad3 signal pathway.